|
Relapsed FL and Novel Agents for Treatment (Part 1) |
08/09/2021 - 5:11pm EDT |
|
First-Line Treatment of Metastatic Triple Negative Breast Cancer |
08/23/2021 - 5:11pm EDT |
|
HIV-Associated Hodgkin Lymphoma |
08/30/2021 - 5:11pm EDT |
|
Management of Hereditary Breast Cancer |
09/13/2021 - 5:11pm EDT |
|
Ph+ B-ALL in Adults |
09/20/2021 - 5:11pm EDT |
|
Cardiotoxicity in Multiple Myeloma Treatment |
09/27/2021 - 5:11pm EDT |
|
Suspected Refractory DLBCL in Medically Fit Patients |
10/04/2021 - 5:11pm EDT |
|
Neoadjuvant therapy for early stage breast cancer |
10/18/2021 - 5:11pm EDT |
|
Immunotherapy in the Treatment of Advanced Driver Negative NSCLC |
10/25/2021 - 5:11pm EDT |
|
First Line Treatment for Early Stage Unfavorable Hodgkin’s Lymphoma |
11/01/2021 - 5:11pm EDT |